826 / 1241
Cho-PET/CT changed the treatment approach in 27% of cases
compared with standard treatment that would have been adopted
without cho-PET/CT.
74 Pca pts referred for first radiotherapy (primary or recurrent
tumor)
Cho-PET/CT is valuable in defining the extent of disease and
supporting therapeutic decisions in the management of prostate
cancer.